Skip to main content

1 Result(s)

within O. Mioduszewska Remove this filter Oncology Remove this filter

and

  1. No Access

    Article

    Rituximab (Mabthera™, rituxan™) in patients with recurrent indolent lymphoma

    The objective of this multiinstitutional study was to evaluate the safety and efficacy of rituximab at standard four weekly doses in patients with recurrent indolent lymphoma. Thirty-eight patients entered int...

    J. Walewski, E. Kraszewska, O. Mioduszewska, J. Romejko-Jarosińska… in Medical Oncology (2001)